Erratum: Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease ( Journal of Proteome Research (2015) 14:12 (5063-5076) DOI:10.1021/acs.jproteome.5b00892);Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease

Journal of Proteome Research

Volumn 14, Issue 12, 2015, Pages 5063-5076

  Liang, Hui Chung ^a   Russell, Claire ^a   Mitra, Vikram ^a   Chung, Raymond ^b   Hye, Abdul ^b   Bazenet, Chantal ^b   Lovestone, Simon ^c   Pike, Ian ^a   Ward, Malcolm ^a  

^a Proteome Sciences plc   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; and biomarker; clusterin; glycosylation; hippocampal atrophy; mass spectrometry; selected reaction monitoring

Indexed keywords

CLUSTERIN; GLYCOPEPTIDE; BIOLOGICAL MARKER; CLU PROTEIN, HUMAN;

AGED; ALPHA CHAIN; ALZHEIMER DISEASE; ARTICLE; BETA CHAIN; BRAIN ATROPHY; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; GLYCOSYLATION; HIGH THROUGHPUT SCREENING; HIPPOCAMPAL ATROPHY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; MALE; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN STRUCTURE; PROTEOMICS; TANDEM MASS SPECTROMETRY; VERY ELDERLY; AMINO ACID SEQUENCE; ATROPHY; BLOOD; CLINICAL TRIAL; COGNITIVE DEFECT; HIPPOCAMPUS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MULTICENTER STUDY; PATHOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ATROPHY; BIOMARKERS; CLUSTERIN; COGNITION DISORDERS; FEMALE; GLYCOSYLATION; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PILOT PROJECTS; TANDEM MASS SPECTROMETRY;

EID: 84948950057     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.6b00080     Document Type: Erratum

References (44)

1. Harold, D.; Abraham, R.; Hollingworth, P.; Sims, R.; Gerrish, A.; Hamshere, M. L.; Pahwa, J. S.; Moskvina, V.; Dowzell, K.; Williams, A.; Jones, N.; Thomas, C.; Stretton, A.; Morgan, A. R.; Lovestone, S.; Powell, J.; Proitsi, P.; Lupton, M. K.; Brayne, C.; Rubinsztein, D. C.; Gill, M.; Lawlor, B.; Lynch, A.; Morgan, K.; Brown, K. S.; Passmore, P. A.; Craig, D.; McGuinness, B.; Todd, S.; Holmes, C.; Mann, D.; Smith, A. D.; Love, S.; Kehoe, P. G.; Hardy, J.; Mead, S.; Fox, N.; Rossor, M.; Collinge, J.; Maier, W.; Jessen, F.; Schürmann, B.; Heun, R.; van den Bussche, H.; Heuser, I.; Kornhuber, J.; Wiltfang, J.; Dichgans, M.; Frölich, L.; Hampel, H.; Hüll, M.; Rujescu, D.; Goate, A. M.; Kauwe, J. S.; Cruchaga, C.; Nowotny, P.; Morris, J. C.; Mayo, K.; Sleegers, K.; Bettens, K.; Engelborghs, S.; De Deyn, P. P.; Van Broeckhoven, C.; Livingston, G.; Bass, N. J.; Gurling, H.; McQuillin, A.; Gwilliam, R.; Deloukas, P.; Al-Chalabi, A.; Shaw, C. E.; Tsolaki, M.; Singleton, A. B.; Guerreiro, R.; Mühleisen, T. W.; Nöthen, M. M.; Moebus, S.; Jöckel, K. H.; Klopp, N.; Wichmann, H. E.; Carrasquillo, M. M.; Pankratz, V. S.; Younkin, S. G.; Holmans, P. A.; O'Donovan, M.; Owen, M. J.; Williams, J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nat. Genet. 2009, 41, 1088-93 10.1038/ng.440
2. Lambert, J. C.; Heath, S.; Even, G.; Campion, D.; Sleegers, K.; Hiltunen, M.; Combarros, O.; Zelenika, D.; Bullido, M. J.; Tavernier, B.; Letenneur, L.; Bettens, K.; Berr, C.; Pasquier, F.; Fiévet, N.; Barberger-Gateau, P.; Engelborghs, S.; De Deyn, P.; Mateo, I.; Franck, A.; Helisalmi, S.; Porcellini, E.; Hanon, O.; European Alzheimer's Disease Initiative Investigators; de Pancorbo, M. M.; Lendon, C.; Dufouil, C.; Jaillard, C.; Leveillard, T.; Alvarez, V.; Bosco, P.; Mancuso, M.; Panza, F.; Nacmias, B.; Bossù, P.; Piccardi, P.; Annoni, G.; Seripa, D.; Galimberti, D.; Hannequin, D.; Licastro, F.; Soininen, H.; Ritchie, K.; Blanché, H.; Dartigues, J. F.; Tzourio, C.; Gut, I.; Van Broeckhoven, C.; Alpérovitch, A.; Lathrop, M.; Amouyel, P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease Nat. Genet. 2009, 41, 1094-9 10.1038/ng.439
3. Nuutinen, T.; Suuronen, T.; Kauppinen, A.; Salminen, A. Clusterin: a forgotten player in Alzheimer's disease Brain Res. Rev. 2009, 61, 89-104 10.1016/j.brainresrev.2009.05.007
4. May, P. C.; Lampert-Etchells, M.; Johnson, S. A.; Poirier, J.; Masters, J. N.; Finch, C. E. Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat Neuron 1990, 5, 831-839 10.1016/0896-6273(90)90342-D
5. Howlett, D. R.; Hortobágyi, T.; Francis, P. T. Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue Brain Pathol. 2013, 23, 623-32 10.1111/bpa.12057
6. Thambisetty, M.; Simmons, A.; Velayudhan, L.; Hye, A.; Campbell, J.; Zhang, Y.; Wahlund, L. O.; Westman, E.; Kinsey, A.; Güntert, A.; Proitsi, P.; Powell, J.; Causevic, M.; Killick, R.; Lunnon, K.; Lynham, S.; Broadstock, M.; Choudhry, F.; Howlett, D. R.; Williams, R. J.; Sharp, S. I.; Mitchelmore, C.; Tunnard, C.; Leung, R.; Foy, C.; O'Brien, D.; Breen, G.; Furney, S. J.; Ward, M.; Kloszewska, I.; Mecocci, P.; Soininen, H.; Tsolaki, M.; Vellas, B.; Hodges, A.; Murphy, D. G.; Parkins, S.; Richardson, J. C.; Resnick, S. M.; Ferrucci, L.; Wong, D. F.; Zhou, Y.; Muehlboeck, S.; Evans, A.; Francis, P. T.; Spenger, C.; Lovestone, S. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease Arch. Gen. Psychiatry 2010, 67, 739-48 10.1001/archgenpsychiatry.2010.78
7. Yu, J.-T.; Lan, T. The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy Mol. Neurobiol. 2012, 45, 314-26 10.1007/s12035-012-8237-1
8. Desikan, R. S.; Thompson, W. K.; Holland, D.; Hess, C. P.; Brewer, J. B.; Zetterberg, H.; Blennow, K.; Andreassen, O. A.; McEvoy, L. K.; Hyman, B. T.; Dale, A. M. The role of clusterin in amyloid-β-associated neurodegeneration JAMA Neurol. 2014, 71, 180-7 10.1001/jamaneurol.2013.4560
9. Schrijvers, E. M.; Koudstaal, P. J.; Hofman, A.; Breteler, M. M. Plasma clusterin and the risk of Alzheimer disease JAMA 2011, 305, 1322-6 10.1001/jama.2011.381
10. Xing, Y.-Y.; Yu, J.-T.; Cui, W.-Z.; Zhong, X.-L.; Wu, Z.-C.; Zhang, Q.; Tan, L. Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease J. Alzheimers Dis. 2012, 29, 515-9 10.3233/JAD-2011-111844
11. Thambisetty, M.; An, Y.; Kinsey, A.; Koka, D.; Saleem, M.; Güntert, A.; Kraut, M.; Ferrucci, L.; Davatzikos, C.; Lovestone, S.; Resnick, S. M. Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment NeuroImage 2012, 59, 212-7 10.1016/j.neuroimage.2011.07.056
12. Hye, A.; Riddoch-Contreras, J.; Baird, A. L.; Ashton, N. J.; Bazenet, C.; Leung, R.; Westman, E.; Simmons, A.; Dobson, R.; Sattlecker, M.; Lupton, M.; Lunnon, K.; Keohane, A.; Ward, M.; Pike, I.; Zucht, H. D.; Pepin, D.; Zheng, W.; Tunnicliffe, A.; Richardson, J.; Gauthier, S.; Soininen, H.; KŁoszewska, I.; Mecocci, P.; Tsolaki, M.; Vellas, B.; Lovestone, S. Plasma proteins predict conversion to dementia from prodromal disease Alzheimer's Dementia 2014, 10, 799-807 10.1016/j.jalz.2014.05.1749
13. Burkey, B. F.; deSilva, H. V.; Harmony JA Intracellular processing of apolipoprotein J precursor to the mature heterodimer J. Lipid Res. 1991, 32, 1039-48
14. Stewart, E. M.; Aquilina, J. A.; Easterbrook-Smith, S. B.; Murphy-Durland, D.; Jacobsen, C.; Moestrup, S.; Wilson, M. R. Effects of glycosylation on the structure and function of the extracellular chaperone clusterin Biochemistry 2007, 46, 1412-22 10.1021/bi062082v
15. Varki, A; Lowe, J. B. Biological Roles of Glycans. 2009. In Essentials of Glycobiology, 2 nd ed.; Varki, A; Cummings, R. D.; Esko, J. D.; Freeze, H. H.; Stanley, P; Bertozzi, C. R.; Hart, G. W.; Etzler, M. E., Eds.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY; Chapter 6.
16. Packer, N. H.; von der Lieth, C. W.; Aoki-Kinoshita, K. F.; Lebrilla, C. B.; Paulson, J. C.; Raman, R.; Rudd, P.; Sasisekharan, R.; Taniguchi, N.; York, W. S. Frontiers in glycomics: bioinformatics and biomarkers in disease Proteomics 2008, 8, 8-20 10.1002/pmic.200700917
17. Schedin-Weiss, S.; Winblad, B.; Tjernberg, L. O. The role of protein glycosylation in Alzheimer disease FEBS J. 2014, 281, 46-62 10.1111/febs.12590
18. Tienari, P. J.; De Strooper, B.; Ikonen, E.; Simons, M.; Weidemann, A.; Czech, C.; Hartmann, T.; Ida, N.; Multhaup, G.; Masters, C. L.; Van Leuven, F.; Beyreuther, K.; Dotti, C. G. The beta-amyloid domain is essential for axonal sorting of amyloid precursor protein EMBO J. 1996, 15, 5218-29
19. McFarlane, I.; Georgopoulou, N.; Coughlan, C. M.; Gillian, A. M.; Breen, K. C. The role of the protein glycosylation state in the control of cellular transport of the amyloid beta precursor protein Neuroscience 1999, 90, 15-25 10.1016/S0306-4522(98)00361-3
20. Nakagawa, K.; Kitazume, S.; Oka, R.; Maruyama, K.; Saido, T. C.; Sato, Y.; Endo, T.; Hashimoto, Y. Sialylation enhances the secretion of neurotoxic amyloid-beta peptides J. Neurochem. 2006, 96, 924-33 10.1111/j.1471-4159.2005.03595.x
21. Akasaka-Manya, K.; Manya, H.; Sakurai, Y.; Wojczyk, B. S.; Kozutsumi, Y.; Saito, Y.; Taniguchi, N.; Murayama, S.; Spitalnik, S. L.; Endo, T. Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer's disease Glycobiology 2010, 20, 99-106 10.1093/glycob/cwp152
22. Kapron, J. T.; Hilliard, G. M.; Lakins, J. N.; Tenniswood, M. P.; West, K. A.; Carr, S. A.; Crabb, J. W. Identification and characterization of glycosylation sites in human serum clusterin Protein Sci. 1997, 6, 2120-33 10.1002/pro.5560061007
23. Maguire, T. M.; Gillian, A. M.; O'Mahony, D.; Coughlan, C. M.; Dennihan, A.; Breen, K. C. A decrease in serum sialyltransferase levels in Alzheimer's disease Neurobiol. Aging 1994, 15, 99-102 10.1016/0197-4580(94)90149-X
24. Fodero, L. R.; Sáez-Valero, J.; Barquero, M. S.; Marcos, A.; McLean, C. A.; Small, D. H. Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid J. Neurochem. 2001, 79, 1022-6 10.1046/j.1471-4159.2001.00640.x
25. Nilselid, A. M.; Davidsson, P.; Nägga, K.; Andreasen, N.; Fredman, P.; Blennow, K. Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms Neurochem. Int. 2006, 48, 718-28 10.1016/j.neuint.2005.12.005
26. Sihlbom, C.; Davidsson, P.; Sjögren, M.; Wahlund, L. O.; Nilsson, C. L. Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals Neurochem. Res. 2008, 33, 1332-40 10.1007/s11064-008-9588-x
27. Ghiso, J.; Matsubara, E.; Koudinov, A.; Choi-Miura, N. H.; Tomita, M.; Wisniewski, T.; Frangione, B. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex Biochem. J. 1993, 293 (Pt 1) 27-30 10.1042/bj2930027
28. Oda, T.; Pasinetti, G. M.; Osterburg, H. H.; Anderson, C.; Johnson, S. A.; Finch, C. E. Purification and characterization of brain clusterin Biochem. Biophys. Res. Commun. 1994, 204, 1131-6 10.1006/bbrc.1994.2580
29. Blaschuk, O. W.; Fritz, I. B. Isoelectric forms of clusterin isolated from ram rete testis fluid and from secretions of primary cultures of ram and rat Sertoli-cell-enriched preparations Biochem. Cell Biol. 1984, 62, 456-61 10.1139/o84-062
30. Picotti, P.; Aebersold, R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions Nat. Methods 2012, 9, 555-66 10.1038/nmeth.2015
31. Lovestone, S.; Francis, P.; Kloszewska, I.; Mecocci, P.; Simmons, A.; Soininen, H.; Spenger, C.; Tsolaki, M.; Vellas, B.; Wahlund, L. O.; Ward, M. AddNeuroMed Consortium: AddNeuroMed-the European collaboration for the discovery of novel biomarkers for Alzheimer's disease Ann. N. Y. Acad. Sci. 2009, 1180, 36-46 10.1111/j.1749-6632.2009.05064.x
32. Lovestone, S.; Francis, P.; Strandgaard, K. Biomarkers for disease modification trials - the innovative medicines initiative and AddNeuroMed J. Nutr. Health Aging 2007, 11, 359-61
33. Hye, A.; Lynham, S.; Thambisetty, M.; Causevic, M.; Campbell, J.; Byers, H. L.; Hooper, C.; Rijsdijk, F.; Tabrizi, S. J.; Banner, S.; Shaw, C. E.; Foy, C.; Poppe, M.; Archer, N.; Hamilton, G.; Powell, J.; Brown, R. G.; Sham, P.; Ward, M.; Lovestone, S. Proteome-based plasma biomarkers for Alzheimer's disease Brain 2006, 129, 3042-50 10.1093/brain/awl279
34. Westman, E.; Simmons, A.; Muehlboeck, J. S.; Mecocci, P.; Vellas, B.; Tsolaki, M.; KŁoszewska, I.; Soininen, H.; Weiner, M. W.; Lovestone, S.; Spenger, C.; Wahlund, L. O. AddNeuroMed consortium; Alzheimer's Disease Neuroimaging Initiative. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America NeuroImage 2011, 58, 818-28 10.1016/j.neuroimage.2011.06.065
35. Ernst, B.; Müller, D. R.; Richter, W. J. False sugar sequence ions in electrospray tandem mass spectrometry of underivatized sialyl-Lewis-type oligosaccharides Int. J. Mass Spectrom. Ion Processes 1997, 160, 283-90 10.1016/S0168-1176(96)04487-4
36. Harvey, D. J.; Mattu, T. S.; Wormald, M. R.; Royle, L.; Dwek, R. A.; Rudd, P. M. Internal residue loss: rearrangements occurring during the fragmentation of carbohydrates derivatized at the reducing terminus Anal. Chem. 2002, 74, 734-40 10.1021/ac0109321
37. Tousi, F.; Bones, J.; Iliopoulos, O.; Hancock, W. S.; Hincapie, M. Multidimensional liquid chromatography platform for profiling alterations of clusterin N-glycosylation in the plasma of patients with renal cell carcinoma J. Proteome Res. 2012, 1256, 121-128 10.1016/j.chroma.2012.07.066
38. Jenne, D. E.; Tschopp, J. Clusterin: the intriguing guises of a widely expressed glycoprotein Trends Biochem. Sci. 1992, 17, 154-159 10.1016/0968-0004(92)90325-4
39. Pajak, B.; Orzechowski, A.; Gajkowska, B. The possible implication of clusterin-dependent serum cholesterol trafficking in Alzheimer's disease Curr. Neurobiol. 2010, 1, 14-20
40. Murphy, B. F.; Kirszbaum, L.; Walker, I. D.; d'Apice, A. J. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis J. Clin. Invest. 1988, 81, 1858-64 10.1172/JCI113531
41. Choi, N. H.; Tobe, T.; Hara, K.; Yoshida, H.; Tomita, M. Sandwich ELISA assay for quantitative measurement of SP-40,40 in seminal plasma and serum J. Immunol. Methods 1990, 131, 159-63 10.1016/0022-1759(90)90186-Y
42. Furney, S. J.; Kronenberg, D.; Simmons, A.; Güntert, A.; Dobson, R. J.; Proitsi, P.; Wahlund, L. O.; Kloszewska, I.; Mecocci, P.; Soininen, H.; Tsolaki, M.; Vellas, B.; Spenger, C.; Lovestone, S. Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease - cytokines and MRI measures together predict disease progression J. Alzheimers Dis. 2011, 226 (Suppl 3) 395-405 10.3233/JAD-2011-0044
43. Zhang, R.; Barker, L.; Pinchev, D.; Marshall, J.; Rasamoelisolo, M.; Smith, C.; Kupchak, P.; Kireeva, I.; Ingratta, L.; Jackowski, G. Mining biomarkers in human sera using proteomic tools Proteomics 2004, 4, 244-56 10.1002/pmic.200300495
44. Afonso-Oramas, D.; Cruz-Muros, I.; de la Rosa, D. A.; Abreu, P.; Giráldez, T.; Castro-Hernández, J.; Salas-Hernández, J.; Lanciego, J. L.; Rodríguez, M.; González-Hernández, T. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease Neurobiol. Dis. 2009, 36, 494-508 10.1016/j.nbd.2009.09.002